|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis: N, S- U! M5 t) r, Q$ m) N- S
was to close its brain research facility in Basel, Switzerland,
6 S1 C) k+ x: i0 Z5 f5 Fthe story noted that this move closely followed similar cuts! s# m- q3 Q* h' U7 c
by rival pharmaceutical firms. As a report from the European College! Z7 ?6 d8 [/ ^$ D
of Neuropsychopharmacology( G" b% ]; @* k: C2 _% A
had warned a few months earlier, the
5 S. x1 H7 f$ P; d, s2 ]; Y+ Zabandonment of research into new psychiatric drugs by AstraZeneca," r# V& e/ b! U+ g# `+ V! c# m( Q
GlaxoSmithKline% y# B" q+ L0 k% E1 R
and others meant that “withdrawal of research
' B0 O% n$ x* A0 yresources is a withdrawal of hope for patients and their families”. ~5 j. \$ N; ^1 J
+ ^( N( V; E% J* u n5 H; w$ j& b' w9 m
回复有免费下载链接
9 m1 `, F8 f$ a1 L
) {6 T+ r) I; Q6 u: W \ |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
